Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 29

1.

Serum Midkine and Osteopontin Levels as Diagnostic Biomarkers of Hepatocellular Carcinoma.

Hodeib H, ELshora O, Selim A, Sabry NM, El-Ashry HM.

Electron Physician. 2017 Jan 25;9(1):3492-3498. doi: 10.19082/3492. eCollection 2017 Jan.

2.

Inhibition of osteopontin reduce the cardiac myofibrosis in dilated cardiomyopathy via focal adhesion kinase mediated signaling pathway.

Zhao H, Wang W, Zhang J, Liang T, Fan GP, Wang ZW, Zhang PD, Wang X, Zhang J.

Am J Transl Res. 2016 Sep 15;8(9):3645-3655. eCollection 2016.

3.

Potential Markers in Cardiac Hypertrophy?

Malinowski B, Fulgheri G, Wicinski M, Grzesk E, Odrowaz-Sypniewska G, Grześk G, Darwish N.

EJIFCC. 2012 Jul 18;23(2):41-6. eCollection 2012 Jul.

4.

Fibroblast-Extracellular Matrix Interactions in Tissue Fibrosis.

Frangogiannis NG.

Curr Pathobiol Rep. 2016 Mar;4(1):11-18. Epub 2016 Feb 5.

5.

Integrins and integrin-related proteins in cardiac fibrosis.

Chen C, Li R, Ross RS, Manso AM.

J Mol Cell Cardiol. 2016 Apr;93:162-74. doi: 10.1016/j.yjmcc.2015.11.010. Epub 2015 Nov 10. Review.

6.

Osteopontin Potentiates Pulmonary Inflammation and Fibrosis by Modulating IL-17/IFN-γ-secreting T-cell Ratios in Bleomycin-treated Mice.

Oh K, Seo MW, Kim YW, Lee DS.

Immune Netw. 2015 Jun;15(3):142-9. doi: 10.4110/in.2015.15.3.142. Epub 2015 Jun 25.

7.

Persistently elevated osteopontin serum levels predict mortality in critically ill patients.

Roderburg C, Benz F, Cardenas DV, Lutz M, Hippe HJ, Luedde T, Trautwein C, Frey N, Koch A, Tacke F, Luedde M.

Crit Care. 2015 Jun 26;19:271. doi: 10.1186/s13054-015-0988-4.

8.

Mechanosensing and Regulation of Cardiac Function.

Dostal DE, Feng H, Nizamutdinov D, Golden HB, Afroze SH, Dostal JD, Jacob JC, Foster DM, Tong C, Glaser S, Gerilechaogetu F.

J Clin Exp Cardiolog. 2014 Jun 5;5(6):314.

9.

Deep sequence analysis of gene expression identifies osteopontin as a downstream effector of integrin-linked kinase (ILK) in cardiac-specific ILK knockout mice.

Dai J, Matsui T, Abel ED, Dedhar S, Gerszten RE, Seidman CE, Seidman JG, Rosenzweig A.

Circ Heart Fail. 2014 Jan;7(1):184-93. doi: 10.1161/CIRCHEARTFAILURE.113.000649. Epub 2013 Dec 6.

10.

Bone sialoprotein and osteopontin in bone metastasis of osteotropic cancers.

Kruger TE, Miller AH, Godwin AK, Wang J.

Crit Rev Oncol Hematol. 2014 Feb;89(2):330-41. doi: 10.1016/j.critrevonc.2013.08.013. Epub 2013 Sep 7. Review.

11.

Expression of osteopontin in patients with thyroid dysfunction.

Reza S, Shaukat A, Arain TM, Riaz QS, Mahmud M.

PLoS One. 2013;8(2):e56533. doi: 10.1371/journal.pone.0056533. Epub 2013 Feb 20.

12.

A modern understanding of the traditional and nontraditional biological functions of angiotensin-converting enzyme.

Bernstein KE, Ong FS, Blackwell WL, Shah KH, Giani JF, Gonzalez-Villalobos RA, Shen XZ, Fuchs S, Touyz RM.

Pharmacol Rev. 2012 Dec 20;65(1):1-46. doi: 10.1124/pr.112.006809. Print 2013 Jan. Review. Erratum in: Pharmacol Rev. 2013;65(1):544.

13.

The extracellular matrix modulates fibroblast phenotype and function in the infarcted myocardium.

Dobaczewski M, de Haan JJ, Frangogiannis NG.

J Cardiovasc Transl Res. 2012 Dec;5(6):837-47. doi: 10.1007/s12265-012-9406-3. Epub 2012 Sep 7. Review.

14.

Extracellular matrix and fibroblast communication following myocardial infarction.

Ma Y, Halade GV, Lindsey ML.

J Cardiovasc Transl Res. 2012 Dec;5(6):848-57. doi: 10.1007/s12265-012-9398-z. Epub 2012 Aug 28. Review.

15.

A new piezoelectric actuator induces bone formation in vivo: a preliminary study.

Reis J, Frias C, Canto e Castro C, Botelho ML, Marques AT, Simões JA, Capela e Silva F, Potes J.

J Biomed Biotechnol. 2012;2012:613403. doi: 10.1155/2012/613403. Epub 2012 May 31.

16.

Matricellular proteins in cardiac adaptation and disease.

Frangogiannis NG.

Physiol Rev. 2012 Apr;92(2):635-88. doi: 10.1152/physrev.00008.2011. Review.

17.

Combining experimental and mathematical modeling to reveal mechanisms of macrophage-dependent left ventricular remodeling.

Jin YF, Han HC, Berger J, Dai Q, Lindsey ML.

BMC Syst Biol. 2011 May 5;5:60. doi: 10.1186/1752-0509-5-60.

18.

Role of matricellular proteins in cardiac tissue remodeling after myocardial infarction.

Matsui Y, Morimoto J, Uede T.

World J Biol Chem. 2010 May 26;1(5):69-80. doi: 10.4331/wjbc.v1.i5.69.

19.

Reduced serum content and increased matrix stiffness promote the cardiac myofibroblast transition in 3D collagen matrices.

Galie PA, Westfall MV, Stegemann JP.

Cardiovasc Pathol. 2011 Nov-Dec;20(6):325-33. doi: 10.1016/j.carpath.2010.10.001. Epub 2011 Feb 8.

20.

Osteopontin: role in extracellular matrix deposition and myocardial remodeling post-MI.

Singh M, Foster CR, Dalal S, Singh K.

J Mol Cell Cardiol. 2010 Mar;48(3):538-43. doi: 10.1016/j.yjmcc.2009.06.015. Epub 2009 Jun 30. Review.

Supplemental Content

Support Center